Nanoparticle-based combination therapy shows promise in colon cancer prevention

November 21, 2011, National Cancer Institute

(PhysOrg.com) -- Using nanoparticles to deliver a cocktail of aspirin and folic acid, researchers at the Western University of Health Sciences (WUHS) have created what could be an effective agent to prevent colon cancer. The nanoparticle formulation, which was simple to prepare, reduced the formation of aberrant crypt foci - an important precursor of colon cancer - by as much as 75 percent in a animal model of colon cancer.

Sunil Prabhu led the research team that developed this polymeric nanoparticle chemoprevention agent. He and his collaborators reported their findings in the journal .

A growing body of evidence suggests that aspirin, the vitamin folic acid, and each act to prevent the development of the that become . Prabhu and his research team had recently shown that a cocktail of these three agents significantly reduced the viability of human lines.

Taking these finding one step further, the WUHS team created a biodegradable polymeric nanoparticle that encapsulates aspirin and folic acid in a simple process. The researchers then coated the nanoparticles with a thin layer of an FDA-approved polymer that drug manufacturers use to make pills that only dissolve in the colon.

Using a well-established animal model of colon cancer, the researchers tested a variety of different dose combinations of the three compounds, both encapsulated in a nanoparticle or given as a combined supplement without nanoparticle encapsulation. Nanoparticle-encapsulated aspirin and folic acid were co-administered with a standard calcium supplement. These experiments showed that both the unmodified and encapsulated treatments, given in a variety of different dosing regimens, were effective at preventing the formation of aberrant crypt foci. However, the nanoparticle-calcium combination containing the lowest doses of aspirin and folic acid were more effective than the regimens using the highest doses of the unencapsulated compounds. One interesting finding was that when folic acid and aspirin were encapsulated separately in different nanoparticles and then administered together with calcium, there seemed to be protective effect.

This work, which was supported by the National Cancer Institute, is detailed in a paper titled, "Chemoprevention of in a Rat Carcinogenesis Model Using a Novel Nanotechnology-Based Combined Treatment System."

Explore further: Polymeric nanoparticles attack head and neck cancer

More information: View abstract

Related Stories

Polymeric nanoparticles attack head and neck cancer

July 15, 2011

Head and neck cancer, the sixth most common cancer in the world, has remained one of the more difficult malignancies to treat, and even when treatment is successful, patients suffer severely from the available therapies. ...

Targeted Nanoparticles Boost Arsenic’s Anticancer Punch

July 22, 2009

Arsenic trioxide has a long history as a potent human poison, but it also has proven valuable as one of the primary treatment options for acute promyelocytic leukemia. Efforts to use arsenic trioxide to treat other types ...

Recommended for you

Sculpting stable structures in pure liquids

February 21, 2019

Oscillating flow and light pulses can be used to create reconfigurable architecture in liquid crystals. Materials scientists can carefully engineer concerted microfluidic flows and localized optothermal fields to achieve ...

LMC S154 is a symbiotic recurrent nova, study suggests

February 21, 2019

Astronomers have conducted observations of a symbiotic star in the Large Magellanic Cloud (LMC), known as LMC S154, which provide new insights about the nature of this object. Results of these observations, presented in a ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.